» Articles » PMID: 37234330

Spectrum of Salivary Gland Diseases: A 24-year Single-institution Retrospective Study

Overview
Date 2023 May 26
PMID 37234330
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Salivary glands are exocrine glands and are classified as major and minor salivary glands. Salivary gland pathologies are classified as neoplastic and non-neoplastic. The neoplasms of salivary glands can be benign or malignant.

Aim: The aim of the study was to describe the frequency of various salivary gland diseases reported in our institution from 1997 to 2021.

Methodology: This was a 24-year retrospective study of salivary gland lesions processed and reported by the Department of Oral Pathology and Microbiology. Data regarding age, gender, site, and diagnosis were obtained and studied.

Results: Amongst the total 5928 biopsied cases reported, 6% were salivary gland pathologies. Two hundred sixty-six were non-neoplastic lesions and 81 were neoplastic. The most common non-neoplastic lesion was mucous extravasation cyst. The most common neoplastic lesion was pleomorphic adenoma.

Conclusion: The frequency of occurrence of salivary gland lesions in the last 24 years of this institution is almost similar to that stated in other published studies.

References
1.
Fowler C, Damm D . Sialadenoma Papilliferum: Analysis of Seven New Cases and Review of the Literature. Head Neck Pathol. 2017; 12(2):193-201. PMC: 5953874. DOI: 10.1007/s12105-017-0852-8. View

2.
Laishram R, Arun Kumar K, Pukhrambam G, Laishram S, Debnath K . Pattern of salivary gland tumors in Manipur, India: A 10 year study. South Asian J Cancer. 2014; 2(4):250-3. PMC: 3889054. DOI: 10.4103/2278-330X.119886. View

3.
Sunil S, Babu S, Panicker S, Pratap N . Sialadenoma papilliferum: A rare case report and review of literature. J Cancer Res Ther. 2017; 13(1):148-151. DOI: 10.4103/0973-1482.187300. View

4.
More C, Bhavsar K, Varma S, Tailor M . Oral mucocele: A clinical and histopathological study. J Oral Maxillofac Pathol. 2014; 18(Suppl 1):S72-7. PMC: 4211243. DOI: 10.4103/0973-029X.141370. View

5.
Di Villeneuve L, Souza I, Tolentino F, Ferrarotto R, Schvartsman G . Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease. Front Oncol. 2020; 10:580141. PMC: 7649804. DOI: 10.3389/fonc.2020.580141. View